Panacea
Panacea is an AI-native FDA regulatory consulting service pairing ex-FDA reviewers with a custom AI platform for 510(k), De Novo, PMA, IND, NDA and BLA
Pick Panacea when you want ex-FDA reviewers running your submission and the cost locked to milestones instead of hours. The combination of consultants who have reviewed and delivered hundreds of FDA filings with a custom FDA-trained AI layer is a credible one, and the vendor's own casework — a PMA vascular radioembolization device, De Novo radiology AI diagnostics, first-of-its-kind BgRT and an IDE RF ablation study — shows breadth across device and pharma pathways. Pass if you want self-serve regulatory software like Greenlight Guru or MasterControl that your own team operates, or if you need EU MDR and non-US filings.
Verified 10d ago · liveness 58/100 · cite: rightaichoice.com/tools/panacea
- Medical device startups needing 510(k) or De Novo clearance on a tight timeline
- Pharma companies preparing IND, NDA or BLA submissions
- Teams that want fixed, milestone-based pricing instead of hourly consultancy billing
- Organizations without a senior in-house regulatory lead
- Companies needing EU MDR or other non-US regulatory filings
- Teams with a strong in-house regulatory function looking only for software tooling
We scan live Reddit threads, YouTube comments, X posts, G2 reviews and other communities — and hand you an honest verdict in under a minute.
- Honest verdict, not marketing
- Real pros & cons from real users
- Attributed quotes with receipts
3 free scans · no card needed
Skip Panacea if you need EU MDR or other non-US regulatory filings, or if you want regulatory software your own team operates rather than a consulting team running the submission for you.
Panacea prices per project on fixed, milestone-based terms, paying out only when defined deliverables are completed, so the number scales with submission complexity rather than headcount or hours. That structure fits funded device and pharma companies carrying a 510(k), De Novo, IND or PMA who want a predictable number. Traditional hourly consultancies can end up costing more once scope creep lands, while self-serve regulatory software like Greenlight Guru or MasterControl costs less but leaves
In short
Panacea — Panacea is an AI-native FDA regulatory consulting service pairing ex-FDA reviewers with a custom AI platform for 510(k), De Novo, PMA, IND, NDA and BLA. Best for Medical device startups needing 510(k) or De Novo clearance on a tight timeline, Pharma companies preparing IND, NDA or BLA submissions, Teams that want fixed, milestone-based pricing instead of hourly consultancy billing. Paid pricing.
What people actually say about Panacea — is it worth it?
We scanned public community sources for Panacea on Sep 24, 2026 and could not establish that the discussion we found is about this tool rather than something else sharing its name. Only 0 of the posts we fetched could be positively tied to Panacea. Rather than publish a sentiment score built on the wrong subject, we publish nothing here and re-run the scan.
Viability Score
How well maintained and how widely used is Panacea? Built from what the vendor actually publishes (docs, changelog, tutorials, integrations, pricing), whether the site is live, and how much real users discuss it. How we calculate this
Last calculated: October 2026
How we score →Key Features
- FDA-trained AI for document analysis and drafting
- Expert-led FDA regulatory pathway strategy and roadmap
- End-to-end submission authoring and final filing
- Pre-FDA meeting preparation and participation
- Pathway coverage: 510(k), De Novo, PMA, IND, NDA and BLA
- Fixed, milestone-based pricing with no hourly billing
- Payment only when defined deliverables are completed
- 100% expert oversight by ex-FDA consultants
- Dedicated regulatory lead per project
- Free initial consultation to scope the project
- Support across all medical device classes and types
- Track record across PMA, De Novo, IDE and 510(k) filings
- Consultants with 15+ years of FDA experience
- AI-native regulatory workflows purpose-built for FDA
- Milestone-driven roadmap from current stage to clearance
About Panacea
Panacea is an AI-native FDA regulatory consulting service, not software you license and run yourself. It combines ex-FDA regulatory experts and AI engineers around a custom AI platform purpose-built for FDA regulatory workflows, and it covers the full pathway spread: 510(k), De Novo, PMA, IND, NDA and BLA. Medical device and pharma companies bring Panacea in when they want experienced reviewers hands-on with the submission instead of another tool for their own team to operate. The engagement runs end to end. Expert-led strategy sets the regulatory pathway and a milestone-driven roadmap from your current stage to approval or clearance; consultants who have reviewed and delivered FDA submissions then drive pre-FDA meetings through authoring and final filing. The vendor states its delivery runs 60% faster than traditional firms, with 100% expert oversight, meaning nothing ships without a human reviewer signing off. The commercial model is the main difference from traditional consultancies: fixed, milestone-based pricing with no hourly billing, and payment only when defined deliverables are completed. Public casework the vendor lists spans a PMA vascular radioembolization device, De Novo radiology AI diagnostics, first-of-its-kind BgRT and an IDE radiofrequency ablation study, with a customer quote from Adialante's CEO citing the fixed, risk-free pricing. Where it sits against alternatives: Greenlight Guru and MasterControl sell regulatory software you operate yourself, while traditional consultancies bill hourly and leave timeline risk with you. Panacea sits between them — a consulting service with AI underneath. It is FDA-only; EU MDR and other global filings are outside its scope.
Behind the Verdict
Panacea's pitch is straightforward: you are buying a regulatory team, not a subscription. The vendor pairs ex-FDA consultants (15+ years spent at the FDA, per the site) with AI engineers and a custom AI platform purpose-built for FDA regulatory workflows. The stated job of that AI layer is document analysis and drafting, compressing timelines and automating manual authoring work while expert oversight stays at 100% — no deliverable goes out without a human reviewer signing off. Strengths. Pathway coverage is genuinely broad for a single shop: 510(k), De Novo, PMA, IDE, IND, NDA and BLA, which means the same partner can carry a device through clearance and a drug-device combination through its clinical and marketing submissions. The commercial structure is the real differentiator — fixed, milestone-based pricing, no hourly billing, and payment only when defined deliverables are completed, with a free initial consultation to scope the project. That removes the open-ended billing exposure that makes traditional regulatory consultancies hard to budget. Public casework spans a PMA vascular radioembolization device, De Novo radiology AI diagnostics, first-of-its-kind BgRT and an IDE radiofrequency ablation study, and the vendor cites a 60% faster delivery claim against traditional firms. Weaknesses and where to be careful. The 60% faster figure is vendor-claimed and depends on project complexity — treat it as a target, not a guarantee. Panacea is FDA-only; EU MDR, UKCA and other global filings are outside scope, so a company with a global launch plan will still need a second partner. And because this is a service rather than a platform, your own team does not end up owning a tool or a document system at the end of the engagement — if you wanted software you operate internally, Greenlight Guru or MasterControl is the other category entirely. Where it fits. Venture-backed device and pharma companies without a senior in-house regulatory lead, teams whose submission timeline is the binding constraint, and organisations that have been burned by hourly consultancy invoices. Where it does not: companies with a strong internal regulatory function looking only for tooling, and anyone whose immediate need is a non-US filing.
Researching Panacea? Get your full AI stack in 60 seconds.
Free, no signup — tell us your goal and get tools matched to your budget & existing stack.
Real-world workflow fit
Concrete scenarios for the personas Panacea actually fits — and what changes day-one when you adopt it.
You book the free initial consultation, Panacea's ex-FDA consultants set the De Novo classification pathway and a milestone roadmap, then drive pre-submission meetings, authoring and final filing with the FDA-trained AI compressing the drafting work.
Outcome: A filed De Novo request with milestone-based billing, so you only pay as each defined deliverable is completed rather than accruing hourly fees.
You hand the program to a dedicated regulatory lead who maps the IND pathway, runs the pre-FDA meeting, and uses the custom AI platform to analyse source documents and draft submission sections under expert review.
Outcome: An IND submission authored under 100% expert oversight, with a fixed project cost locked before work starts.
You replace an open-ended hourly consultancy mid-program, scope the remaining 510(k) work as fixed milestones with Panacea, and have their team take over authoring and final filing from your current stage.
Outcome: Predictable project economics with payment tied to completed deliverables, and no execution risk left on your balance sheet for the remaining submission work.
Use Cases
- Accelerate a 510(k) submission for a new medical device with AI-assisted drafting.
- Define the optimal regulatory pathway for a novel drug-device combination product.
- Prepare for pre-submission meetings with the FDA using ex-FDA guidance.
- Transition from hourly consulting to fixed, milestone-based regulatory project pricing.
- Compress the timeline for a De Novo classification request using FDA-trained AI tools.
- Manage a complex PMA submission with end-to-end expert support.
- Budget a regulatory program with predictable milestone costs instead of open-ended hours.
Limitations
- Timeline improvements are vendor-claimed — the 60% faster figure against traditional firms depends on project complexity and is not guaranteed.
- Panacea is FDA-only, so EU MDR, UKCA and other global filings fall outside its scope and need a separate partner.
- It is a consulting engagement rather than a platform you operate: your team does not end up owning regulatory software or a document system after the project.
- The underlying AI model is not disclosed.
- The only stated access point is a web contact and free-consultation flow, so project scope, milestones and cost are settled with the team rather than published.
as of 2026-09-28
Verification history
We have re-verified Panacea 7 times since . Each pass re-reads the vendor's own pages and re-checks every listed field against that evidence; passes where nothing had changed are marked as such.
- — re-verified summary, description, our verdict, our analysis, pricing model, pricing tiers, features, integrations, who it suits, who should skip it
- — re-verified summary, description, our verdict, our analysis, pricing model, pricing tiers, features, integrations, who it suits, who should skip it
- — re-verified summary, description, our verdict, our analysis, pricing model, pricing tiers, features, integrations, who it suits, who should skip it
- — re-verified summary, description, our verdict, our analysis, pricing model, pricing tiers, features, integrations, who it suits, who should skip it
- — re-verified summary, description, our verdict, our analysis, pricing model, pricing tiers, features, integrations, who it suits, who should skip it
- — re-verified summary, description, our verdict, our analysis, pricing model, pricing tiers, features, integrations, who it suits, who should skip it
Showing the 6 most recent of 7 verification passes.
Free to cite with attribution — this page re-verifies continuously.
12-month cost
Project the real annual outlay, including the implied monthly cost when only an annual tier is published.
Vendor list price only. Add-on usage, seat overages, and contract minimums are surfaced under Hidden costs & gotchas.
Plans compared
For each published Panacea tier: who it actually fits, and what it adds vs. the previous tier. Cross-reference the cost calculator above for projected annual outlay.
Fixed Milestone-Based Pricing
Custom
Ideal for
Funded device or pharma companies carrying a 510(k), De Novo, PMA, IND, NDA or BLA who want a predictable project cost and no exposure to hourly overruns.
What this tier adds
Starting engagement model: no hourly billing, payment only when defined deliverables are completed, and the project scoped after a free initial consultation.
Where the pricing makes sense
The company stage and team size where Panacea's pricing actually pencils out — and where peers do it cheaper.
Panacea prices per project on fixed, milestone-based terms, paying out only when defined deliverables are completed, so the number scales with submission complexity rather than headcount or hours. That structure fits funded device and pharma companies carrying a 510(k), De Novo, IND or PMA who want a predictable number. Traditional hourly consultancies can end up costing more once scope creep lands, while self-serve regulatory software like Greenlight Guru or MasterControl costs less but leaves
Setup time & first value
How long it actually takes to get something useful out of Panacea — broken out by persona, not the marketing-page minute.
For a device startup, first value is the free initial consultation, where the pathway and a milestone roadmap are scoped — expect days, not weeks, to a defined plan. Pharma teams with a larger document set should budget longer for the scoping pass, since the AI document analysis and drafting work depends on how much source material you already have organised. Once milestones are agreed, the
Switching to or from Panacea
How to bring data in from common predecessors and how to get it back out — written for the switcher, not the buyer.
- →From an hourly regulatory consultancy: Panacea takes over from your current stage and re-scopes the remaining work as fixed milestones, so you stop accruing open-ended hours.
- →From in-house authoring: hand source documents to the dedicated regulatory lead, who maps them to the FDA pathway and drives pre-meeting through final filing.
- →From Greenlight Guru or MasterControl software: keep what you have built, and Panacea's consultants run the submission work your team was doing inside the tool.
- →From no formal regulatory process: the free initial consultation establishes the pathway and milestone roadmap before any authoring begins.
- ↗To a self-serve regulatory platform such as Greenlight Guru or MasterControl: you would move the ongoing document control and submission management in-house once your team has the regulatory headcount.
- ↗To a global regulatory consultancy: required if you expand beyond FDA into EU MDR, UKCA or other non-US filings, which Panacea does not cover.
Resources & Guides
Tutorials & Learning
YouTube returned 6 videos for “Panacea”, and we withheld 6: 6 could not be judged, because “Panacea” is a single word that other videos use for other things. We are showing none, because we could not prove any of them are about Panacea.
Official links
Tools that pair well with Panacea
Common stack mates teams adopt alongside Panacea, with the specific reason each pairing earns its keep.
Quibim
Cloud-based medical imaging platform that turns MRI, CT, and PET scans into regulatory-cleared quantitative imaging biomarkers.
Workiva
Governed reporting platform that links finance, risk, and sustainability data so every number and narrative stays traceable and audit-ready.
FundRobin
FundRobin connects grant discovery, organisational knowledge, grounded AI proposal drafting, and application tracking in one workflow for mission-led teams.
Featured Head-to-Head Comparisons
Panacea vs Codametrix
Panacea is the right choice for medical device or pharma companies needing fast, fixed-price FDA submission support with AI acceleration and ex-FDA oversight. CodaMetrix dominates for large health systems wanting end-to-end medical coding automation and proven ROI (5:1, 30% cost reduction).
Panacea vs Rapidsos
RapidSOS is the clear choice for 911 centers and enterprises needing AI-enhanced emergency response with device integrations and drone support. Panacea is a specialized regulatory service for medical/ pharma companies seeking faster, fixed-price FDA submissions, but its latest news suggests a pivot away from its core offering. Buyers should verify Panacea's current focus before engaging.
Panacea vs Isomorphic Labs
If you're a large pharma looking for cutting-edge AI drug discovery and can invest in multi-year partnerships, Isomorphic Labs is the choice. For startups or companies needing faster, fixed-cost FDA submissions with expert oversight, Panacea is the clear winner. They serve completely different needs.
Alternatives to Panacea
View all
Quibim
Cloud-based medical imaging platform that turns MRI, CT, and PET scans into regulatory-cleared quantitative imaging biomarkers.
Frequently Asked Questions
Used Panacea? Help shape our editorial sentiment research.